Nektar Therapeutics (NKTR) Deferred Taxes (2022 - 2024)
Nektar Therapeutics (NKTR) posted quarterly Deferred Taxes of -$31000.0 for Q3 2024, down 106.67% year-over-year from $465000.0 in Q4 2023, and down 154.39% quarter-over-quarter from $57000.0 in Q2 2024.
Nektar Therapeutics (NKTR) Deferred Taxes (2022 - 2024) Analysis & Trends
Nektar Therapeutics' Deferred Taxes history runs 3 years deep, the most recent figure standing at -$31000.0 for Q3 2024.
- In Q3 2024, Deferred Taxes fell 106.67% year-over-year to -$31000.0; the TTM figure through Sep 2024 stood at $1.7 million (up 99.3% YoY), while the FY2023 annual figure was -$140000.0, down 105.17% from the prior year.
- Deferred Taxes for Q3 2024 stood at -$31000.0, down from $57000.0 in the prior quarter.
- The five-year high for Deferred Taxes was $2.7 million in Q4 2022, with the low at -$1.8 million in Q1 2023.
- The 3-year median for Deferred Taxes is -$21000.0 (2023), against an average of $319500.0.
- Peak annual rise in Deferred Taxes reached 311.11% in 2024, while the deepest fall reached 106.67% in 2024.
- Nektar Therapeutics' Deferred Taxes stood at $2.7 million in 2022, then plunged by 36.71% to $1.7 million in 2023, then plunged by 101.81% to -$31000.0 in 2024.
- Business Quant data shows NKTR's Deferred Taxes at -$31000.0 in Q3 2024, $57000.0 in Q2 2024, and -$38000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -137,876.64 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.66 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Nektar Therapeutics | 1.49 Bn | 919.46 Mn | 3.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -31,000.00 |
| Jun 30, 2024 | 57,000.00 |
| Mar 31, 2024 | -38,000.00 |
| Dec 31, 2023 | 1.71 Mn |
| Sep 30, 2023 | -15,000.00 |
| Jun 30, 2023 | -27,000.00 |
| Mar 31, 2023 | -1.81 Mn |
| Dec 31, 2022 | 2.71 Mn |